1 Min Read
Nov 10 (Reuters) - Knight Therapeutics Inc
* Qtrly diluted earnings per share $0.04
* All figures in c$
* Knight reports third quarter 2016 results Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.